Stockreport

Entero Therapeutics to Present Corporate Update at 2024 BIO International Convention

Entero Therapeutics Inc.  (ENTO) 
PDF BOCA RATON, Fla., May 22, 2024 (GLOBE NEWSWIRE) --  Entero Therapeutics, Inc. (formerly First Wave BioPharma, Inc.) (Nasdaq: ENTO) (“Entero” or the “Company”), a late [Read more]